Literature DB >> 2104921

Kappa B-type enhancers are involved in lipopolysaccharide-mediated transcriptional activation of the tumor necrosis factor alpha gene in primary macrophages.

A N Shakhov1, M A Collart, P Vassalli, S A Nedospasov, C V Jongeneel.   

Abstract

We have explored the cis-acting elements necessary for the LPS-mediated activation of the mouse TNF-alpha promoter by transfecting a set of 5' deletion mutants linked to the CAT reporter gene into primary bone marrow-derived macrophages. A major drop in inducibility by LPS was seen upon deletion of a region mapping between nt -655 and nt -451. Gel retardation assays revealed that LPS induced the appearance in this region of several specific DNA-protein complexes mapping to sequence motifs with strong homology to the kappa B enhancer. Constructs containing two or more copies of one of the kappa B enhancer motifs linked to a heterologous promoter were inducible by LPS. Additional deletion of a region between nt -301 and nt -241, which contains a MHC class II-like "Y box" and formed a Y box-specific complex with a protein whose concentration was increased by LPS, caused a nearly complete loss of inducibility by LPS. We speculate that NF-kappa B and/or related proteins are involved in the LPS-induced transcriptional activation of the TNF-alpha gene, and that factors interacting with the Y box can additionally modulate the activity of the gene in macrophages.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2104921      PMCID: PMC2187654          DOI: 10.1084/jem.171.1.35

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  34 in total

1.  Multiple nuclear factors interact with the immunoglobulin enhancer sequences.

Authors:  R Sen; D Baltimore
Journal:  Cell       Date:  1986-08-29       Impact factor: 41.582

2.  Tumour necrosis factor and lymphotoxin genes map close to H-2D in the mouse major histocompatibility complex.

Authors:  U Müller; C V Jongeneel; S A Nedospasov; K F Lindahl; M Steinmetz
Journal:  Nature       Date:  1987 Jan 15-21       Impact factor: 49.962

3.  Tumor necrosis factors: gene structure and biological activities.

Authors:  D V Goeddel; B B Aggarwal; P W Gray; D W Leung; G E Nedwin; M A Palladino; J S Patton; D Pennica; H M Shepard; B J Sugarman
Journal:  Cold Spring Harb Symp Quant Biol       Date:  1986

4.  Human growth hormone as a reporter gene in regulation studies employing transient gene expression.

Authors:  R F Selden; K B Howie; M E Rowe; H M Goodman; D D Moore
Journal:  Mol Cell Biol       Date:  1986-09       Impact factor: 4.272

5.  Tandem arrangement of genes coding for tumor necrosis factor (TNF-alpha) and lymphotoxin (TNF-beta) in the human genome.

Authors:  S A Nedospasov; A N Shakhov; R L Turetskaya; V A Mett; M M Azizov; G P Georgiev; V G Korobko; V N Dobrynin; S A Filippov; N S Bystrov
Journal:  Cold Spring Harb Symp Quant Biol       Date:  1986

6.  Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells.

Authors:  C M Gorman; L F Moffat; B H Howard
Journal:  Mol Cell Biol       Date:  1982-09       Impact factor: 4.272

7.  The genes for tumor necrosis factor (TNF-alpha) and lymphotoxin (TNF-beta) are tandemly arranged on chromosome 17 of the mouse.

Authors:  S A Nedospasov; B Hirt; A N Shakhov; V N Dobrynin; E Kawashima; R S Accolla; C V Jongeneel
Journal:  Nucleic Acids Res       Date:  1986-10-10       Impact factor: 16.971

8.  Tissue-specific in vitro transcription from the mouse albumin promoter.

Authors:  K Gorski; M Carneiro; U Schibler
Journal:  Cell       Date:  1986-12-05       Impact factor: 41.582

9.  Control of cachectin (tumor necrosis factor) synthesis: mechanisms of endotoxin resistance.

Authors:  B Beutler; N Krochin; I W Milsark; C Luedke; A Cerami
Journal:  Science       Date:  1986-05-23       Impact factor: 47.728

10.  Gamma interferon enhances macrophage transcription of the tumor necrosis factor/cachectin, interleukin 1, and urokinase genes, which are controlled by short-lived repressors.

Authors:  M A Collart; D Belin; J D Vassalli; S de Kossodo; P Vassalli
Journal:  J Exp Med       Date:  1986-12-01       Impact factor: 14.307

View more
  219 in total

1.  Inhibitory effect of (-)-epigallocatechin gallate on titanium particle-induced TNF-α release and in vivo osteolysis.

Authors:  Shan Jin; Ju Young Park; Jung Min Hong; Tae Ho Kim; Hong In Shin; Eui Kyun Park; Shin Yoon Kim
Journal:  Exp Mol Med       Date:  2011-07-30       Impact factor: 8.718

2.  Characterization of a new tissue-specific transcription factor binding to the simian virus 40 enhancer TC-II (NF-kappa B) element.

Authors:  A L Lattion; E Espel; P Reichenbach; C Fromental; P Bucher; A Israël; P Baeuerle; N R Rice; M Nabholz
Journal:  Mol Cell Biol       Date:  1992-11       Impact factor: 4.272

3.  trans activation of the tumor necrosis factor alpha promoter by the human T-cell leukemia virus type I Tax1 protein.

Authors:  H Albrecht; A N Shakhov; C V Jongeneel
Journal:  J Virol       Date:  1992-10       Impact factor: 5.103

4.  Oxidized low density lipoprotein inhibits lipopolysaccharide-induced binding of nuclear factor-kappaB to DNA and the subsequent expression of tumor necrosis factor-alpha and interleukin-1beta in macrophages.

Authors:  B G Ohlsson; M C Englund; A L Karlsson; E Knutsen; C Erixon; H Skribeck; Y Liu; G Bondjers; O Wiklund
Journal:  J Clin Invest       Date:  1996-07-01       Impact factor: 14.808

Review 5.  The Two Faces of Adjuvant Glucocorticoid Treatment in Ovarian Cancer.

Authors:  Vladimir Djedovic; Yoo-Young Lee; Alexandra Kollara; Taymaa May; Theodore J Brown
Journal:  Horm Cancer       Date:  2018-01-08       Impact factor: 3.869

6.  Autocrine tumor necrosis factor alpha links endoplasmic reticulum stress to the membrane death receptor pathway through IRE1alpha-mediated NF-kappaB activation and down-regulation of TRAF2 expression.

Authors:  Ping Hu; Zhang Han; Anthony D Couvillon; Randal J Kaufman; John H Exton
Journal:  Mol Cell Biol       Date:  2006-04       Impact factor: 4.272

7.  Dimethyl sulfoxide modulates NF-kappa B and cytokine activation in lipopolysaccharide-treated murine macrophages.

Authors:  K A Kelly; M R Hill; K Youkhana; F Wanker; J M Gimble
Journal:  Infect Immun       Date:  1994-08       Impact factor: 3.441

8.  CD46-utilizing adenoviruses inhibit C/EBPbeta-dependent expression of proinflammatory cytokines.

Authors:  Milena Iacobelli-Martinez; Ronald R Nepomuceno; Jodi Connolly; Glen R Nemerow
Journal:  J Virol       Date:  2005-09       Impact factor: 5.103

9.  Structural and functional characterization of the promoter regions of the NFKB2 gene.

Authors:  L Lombardi; P Ciana; C Cappellini; D Trecca; L Guerrini; A Migliazza; A T Maiolo; A Neri
Journal:  Nucleic Acids Res       Date:  1995-06-25       Impact factor: 16.971

10.  Contribution of double-stranded RNA and CPSF30 binding domains of influenza virus NS1 to the inhibition of type I interferon production and activation of human dendritic cells.

Authors:  Irene Ramos; Elena Carnero; Dabeiba Bernal-Rubio; Christopher W Seibert; Liset Westera; Adolfo García-Sastre; Ana Fernandez-Sesma
Journal:  J Virol       Date:  2012-12-19       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.